mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
0.054 |
0.6 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.078 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
Panobinostat |
FIMM |
pan-cancer |
AAC |
0.056 |
0.6 |